Sequential hemibody and local irradiation with combination chemotherapy for small cell lung carcinoma: A preliminary analysis
β Scribed by Bayard L. Powell; Don V. Jackson Jr.; Charles W. Scarantino; Ellen Pope; Robert Choplin; Johnny B. Craig; James N. Atkins; M.Robert Cooper; Judith O. Hopkins; Renee McMahan; Hyman B. Muss; Frederick Richards II; John J. Stuart; Douglas R. White; Patricia Zekan; Charles L. Spurr; Robert L. Capizzi
- Publisher
- Elsevier Science
- Year
- 1985
- Tongue
- English
- Weight
- 790 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Twenty previously untreated patients with small cell carcinoma of the lung were treated with cyclophosphamide, 400 mg/m2 and Adriamycin, 40 mg/m2 IV on day 1, followed by cytosine arabinoside, 20 mg/m2, every 12 hours subcutaneously on days 5--9; this regimen was repeated every 28 days. On days 14--
The development of drug resistance limits the survival or patients with small cell anaplastic carcinoma of the lung (SCLC). The present study was undertaken to overcome this problem by administering two alternating noncross resistant combination chemotherapy regimens. One-hundred-one patients were e
We have carried out a randomized phase Ill study in 105 patients with advanced nonsmall cell lung cancer, comparing a fourdrug cisplatin-mitomycin-based combination chemotherapy regimen t o sequential single-agent therapy. The combination chemotherapy regimen consisted of mitomycin C (10 mg/m2), vin